Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1976 Feb;3(1 Suppl 1):91–95. doi: 10.1111/j.1365-2125.1976.tb03721.x

The assessment of drugs in obsessional states.

R Philpott
PMCID: PMC2958718  PMID: 973952

Full text

PDF
91

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Capstick N. Chlorimipramine in obsessional states. (A pilot study). Psychosomatics. 1971 Sep-Oct;12(5):332–335. doi: 10.1016/S0033-3182(71)71497-2. [DOI] [PubMed] [Google Scholar]
  2. Capstick N., Seldrup J. Phenomenological aspects of obsessional patients treated with clomipramine. Br J Psychiatry. 1973 Jun;122(571):719–720. doi: 10.1192/bjp.122.6.719. [DOI] [PubMed] [Google Scholar]
  3. Collins G. H. The use of parenteral and oral chlorimipramine (Anafranil) in the treatment of depressive states. Br J Psychiatry. 1973 Feb;122(567):189–190. doi: 10.1192/bjp.122.2.189. [DOI] [PubMed] [Google Scholar]
  4. Cooper J., Kelleher M. The Leyton Obsessional Inventory: a principal components analysis on normal subjects. Psychol Med. 1973 May;3(2):204–208. doi: 10.1017/s0033291700048534. [DOI] [PubMed] [Google Scholar]
  5. Cooper J. The Leyton obsessional inventory. Psychol Med. 1970 Nov;1(1):48–64. doi: 10.1017/s0033291700040010. [DOI] [PubMed] [Google Scholar]
  6. Fernández Córdoba E., López-Ibor Aliño J. La monoclorimipramina en enfermos psiquiátricos resistentes a otros tratamientos. Actas Luso Esp Neurol Psiquiatr. 1967 Jun;26(2):119–147. [PubMed] [Google Scholar]
  7. Freed A., Kerr T. A., Roth M. The treatment of obsessional neurosis. Br J Psychiatry. 1972 May;120(558):590–591. doi: 10.1192/bjp.120.558.590-b. [DOI] [PubMed] [Google Scholar]
  8. Gelder M. G., Marks I. M. Severe agoraphobia: a controlled prospective trial of behaviour therapy. Br J Psychiatry. 1966 Mar;112(484):309–319. doi: 10.1192/bjp.112.484.309. [DOI] [PubMed] [Google Scholar]
  9. Gillan P., Rachman S. An experimental investigation of desensitization in phobic patients. Br J Psychiatry. 1974 Apr;124(0):392–401. doi: 10.1192/bjp.124.4.392. [DOI] [PubMed] [Google Scholar]
  10. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HAMILTON M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50–55. doi: 10.1111/j.2044-8341.1959.tb00467.x. [DOI] [PubMed] [Google Scholar]
  12. Hodgson R., Rachman S., Marks I. M. The treatment of chronic obsessive-compulsive neurosis: follow-up and further findings. Behav Res Ther. 1972 May;10(2):181–189. doi: 10.1016/s0005-7967(72)80012-3. [DOI] [PubMed] [Google Scholar]
  13. Johnston D., Gath D. Arousal levels and attribution effects in diazepam-assisted flooding. Br J Psychiatry. 1973 Oct;123(575):463–466. doi: 10.1192/bjp.123.4.463. [DOI] [PubMed] [Google Scholar]
  14. Kelleher M. J. Cross-national (Anglo-Irish) differences in obsessional symptoms and traits of personality. Psychol Med. 1972 Feb;2(1):33–41. doi: 10.1017/s003329170004558x. [DOI] [PubMed] [Google Scholar]
  15. Kellner R. 2. Improvement criteria in drug trials with neurotic patients. Psychol Med. 1972 Feb;2(1):73–80. doi: 10.1017/s0033291700045645. [DOI] [PubMed] [Google Scholar]
  16. Kendell R. E., Discipio W. J. Obsessional symptoms and obsessional personality traits in patients with depressive illnesses. Psychol Med. 1970 Nov;1(1):65–72. doi: 10.1017/s0033291700040022. [DOI] [PubMed] [Google Scholar]
  17. Marks I. M., Gelder M. G. Transvestism and fetishism: clinical and psychological changes during faradic aversion. Br J Psychiatry. 1967 Jul;113(500):711–729. doi: 10.1192/bjp.113.500.711. [DOI] [PubMed] [Google Scholar]
  18. Marks I. M. New approaches to the treatment of obsessive-compulsive disorders. J Nerv Ment Dis. 1973 Jun;156(6):420–426. doi: 10.1097/00005053-197306000-00007. [DOI] [PubMed] [Google Scholar]
  19. Marks I. M. Research in neurosis: a selective review. 2. Treatment. Psychol Med. 1974 Feb;4(1):89–109. doi: 10.1017/s0033291700040344. [DOI] [PubMed] [Google Scholar]
  20. Marks I. M., Viswanathan R., Lipsedge M. S., Gardner R. Enhanced relief of phobias by flooding during waning diazepam effect. Br J Psychiatry. 1972 Nov;121(564):493–505. doi: 10.1192/bjp.121.5.493. [DOI] [PubMed] [Google Scholar]
  21. Marshall W. K. Treatment of obsessional illnesses and phobic anxiety states with clomipramine. Br J Psychiatry. 1971 Oct;119(551):467–468. doi: 10.1192/bjp.119.551.467. [DOI] [PubMed] [Google Scholar]
  22. Rachman S., Hodgson R., Marks I. M. The treatment of chronic obsessive-compulsive neurosis. Behav Res Ther. 1971 Aug;9(3):237–247. doi: 10.1016/0005-7967(71)90009-x. [DOI] [PubMed] [Google Scholar]
  23. Rachman S., Marks I. M., Hodgson R. The treatment of obsessive-compulsive neurotics by modelling and flooding in vivo. Behav Res Ther. 1973 Nov;11(4):463–471. doi: 10.1016/0005-7967(73)90105-8. [DOI] [PubMed] [Google Scholar]
  24. Rachman S. Primary obsessional slowness. Behav Res Ther. 1974 Feb;12(1):9–18. doi: 10.1016/0005-7967(74)90026-6. [DOI] [PubMed] [Google Scholar]
  25. Tan E., Marks I. M., Marset P. Bimedial leucotomy in obsessive-compulsive neurosis: a controlled serial enquiry. Br J Psychiatry. 1971 Feb;118(543):155–164. doi: 10.1192/bjp.118.543.155. [DOI] [PubMed] [Google Scholar]
  26. Tyrer P., Candy J., Kelly D. Phenelzine in phobic anxiety: a controlled trial. Psychol Med. 1973 Feb;3(1):120–124. doi: 10.1017/s0033291700046419. [DOI] [PubMed] [Google Scholar]
  27. Van Renynghe de Voxvrie L'anafranil (G 34586) dans l'obsession. Acta Neurol Psychiatr Belg. 1968 Oct;68(10):787–792. [PubMed] [Google Scholar]
  28. Watson J. P., Gaind R., Marks I. M. Prolonged exposure: a rapid treatment for phobias. Br Med J. 1971 Jan 2;1(5739):13–15. doi: 10.1136/bmj.1.5739.13. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES